The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
Open accessAbstract
Olfactory dysfunction is an early and common symptom in Parkinson's disease (PD). In an effort to determine whether otherwise unexplained (idiopathic) olfactory dysfunction is associated with an increased risk of developing PD, we designed a prospective study in a cohort of 361 asymptomatic relatives (parents, siblings, or children) of PD patients. A combination of olfactory detection, identification, and discrimination tasks was used to select groups of hyposmic (n = 40) and normosmic (n = 38) individuals for a 2‐year clinical follow‐up evaluation and sequential single‐photon emission computed tomography (SPECT), using [123 I]β‐CIT as a dopamine transporter ligand, to assess nigrostriatal dopaminergic function at baseline and 2 years from baseline. A validated questionnaire, sensitive to the presence of parkinsonism, was used in the follow‐up of the remaining 283 relatives. Two years from baseline, 10% of the individuals with idiopathic hyposmia, who also had strongly reduced [123 I]β‐CIT binding at baseline, had developed clinical PD as opposed to none of the other relatives in the cohort. In the remaining nonparkinsonian hyposmic relatives, the average rate of decline in dopamine transporter binding was significantly higher than in the normosmic relatives. These results indicate that idiopathic olfactory dysfunction is associated with an increased risk of developing PD of at least 10%. Ann Neurol 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Recent neuropathological observations show extensive extranigral neuropathological changes in idiopathic PD, including the olfactory bulb and related portions of the anterior olfactory nucleus.(17,36,37) In the novel and challenging pathological staging system for PD put forward by Braak and colleagues, Lewy body path…”
BackgroundAGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
Holloway, R. G., Shoulson, I., Kieburtz, K. D., McDermott, M., Tariot, P. N., Kamp, C., Day, D., Shinaman, A., Fahn, S., Lang, A. E., et al. (2000) · JAMA · Cited by 798
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A Randomized Controlled Trial
Parkinson Study Group (2000) · JAMA · doi:10.1001/jama.284.15.1931 · Cited by 767
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., & Evans, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340202 · Cited by 659
Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 510
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky, S. T., & Marek, K. (2003) · Science · doi:10.1126/science.1090349 · Cited by 406
Olfactory dysfunction in Parkinson's disease.
Hawkes, C. H., Shephard, B. C., & Daniel, S. E. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.5.436 · Cited by 396
Berg, D., Roggendorf, W., Schröder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 377
Olfactory function in patients with Parkinson's disease
Ansari, K. A., & Johnson, A. (1975) · Journal of Chronic Diseases · doi:10.1016/0021-9681(75)90058-2 · Cited by 373
[ 123 I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression
Marek, K., Innis, R., van Dyck, C., Fussell, B., Early, M., Eberly, S., Oakes, D., & Seibyl, J. (2001) · Neurology · doi:10.1212/wnl.57.11.2089 · Cited by 347
Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.
Doty, R. L., Stern, M. B., Pfeiffer, C., Gollomp, S. M., & Hurtig, H. I. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.2.138 · Cited by 328
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. (2004) · Movement Disorders · doi:10.1002/mds.10713 · Cited by 313
Berendse, H. W., Booij, J., Francot, C. M. J. E., Bergmans, P. L. M., Hijman, R., Stoof, J. C., & Wolters, E. C. (2001) · Annals of Neurology · doi:10.1002/ana.1049 · Cited by 299
Self-citationThe anterior olfactory nucleus in Parkinson's disease
Pearce, R. K. B., Hawkes, C. H., & Daniel, S. E. (1995) · Movement Disorders · doi:10.1002/mds.870100309 · Cited by 290
Tissingh, G., Berendse, H. W., Bergmans, P., DeWaard, R., Drukarch, B., Stoof, J. C., & Wolters, E. C. (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<41::aid-mds1017>3.0.co;2-m · Cited by 267
Self-citationAge-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
van Dyck, C. H., Seibyl, J. P., Malison, R. T., Laruelle, M. A., Wallace, E. A., Zoghbi, S. S., Zea‐Ponce, Y., Baldwin, R. M., Charney, D. S., & Hoffer, P. B. (1995) · PubMed · Cited by 226
Pirker, W., Djamshidian, S., Asenbaum, S., Gerschlager, W., Tribl, G., Hoffmann, M., & Brücke, T. (2002) · Movement Disorders · doi:10.1002/mds.1265 · Cited by 213
Increased risk of Parkinson's disease in parents and siblings of patients
Payami, H., Larsen, K., Bernard, S., & Nutt, J. (1994) · Annals of Neurology · doi:10.1002/ana.410360417 · Cited by 211
Olfactory impairment in Parkinson's disease
Ward, C. D., Hess, W. A., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.943 · Cited by 195
Booij, J., Tissingh, G., Winogrodzka, A., & van Royen, E. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050374 · Cited by 174
Self-citationOlfactory threshold in Parkinson's disease.
Quinn, N. P., Rossor, M. N., & MARSDEN, C. D. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.1.88 · Cited by 155
Progression of gait disorder and rigidity and risk of death in older persons
Wilson, R. S., Schneider, J. A., Beckett, L. A., Evans, D. A., & Bennett, D. A. (2002) · Neurology · doi:10.1212/wnl.58.12.1815 · Cited by 154
Tissingh, G., Bergmans, P., Booij, J., Winogrodzka, A., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1997) · Journal of Neurology · doi:10.1007/s004150050168 · Cited by 140
Self-citationTissingh, G., Booij, J., Bergmans, P., Winogrodzka, A., Janssen, A. G. M., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1998) · PubMed · Cited by 140
Self-citationStudies of Human Olfaction from the University of Pennsylvania Smell and Taste Center
Doty, R. L. (1997) · Chemical Senses · doi:10.1093/chemse/22.5.565 · Cited by 119
Abnormal performance on the PD test battery by asymptomatic first-degree relatives
Montgomery, E. B., Baker, K. B., Lyons, K., & Koller, W. C. (1999) · Neurology · doi:10.1212/wnl.52.4.757 · Cited by 89
Screening Parkinson's disease: A validated questionnaire of high specificity and sensitivity
Duarte, J., Clavería, L. E., de Pedro-Cuesta, J., Sempere, Á. P., Coria, F., & Calne, D. B. (1995) · Movement Disorders · doi:10.1002/mds.870100518 · Cited by 88
Olfactory dysfunction in familial parkinsonism
Markopoulou, K., Larsen, K. W., Wszolek, E. K., Denson, M. A., Lang, A. E., Pfeiffer, R. F., & Wszołek, Z. K. (1997) · Neurology · doi:10.1212/wnl.49.5.1262 · Cited by 72
Preclinical diagnosis of Parkinson's disease.
Horstink, M. W. I. M., & Morrish, P. (1999) · PubMed · Cited by 54
“Familial Parkinson's Disease” – A Case-Control Study of Families
Uitti, R. J., Shinotoh, H., Hayward, M., et al. (1997) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100021454 · Cited by 36
Preclinical Parkinson's disease
Tetrud, J. W. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.69 · Cited by 34
Cited by
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Metadata
- Authors
- Ponsen, M. M., Stoffers, D., Booij, J., van Eck‐Smit, B. L. F., Wolters, E. C., & Berendse, H. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-07-19
- Volume
- 56
- Issue
- 2
- Pages
- 173-181
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2117535122
- Cited by
- 740
- References
- 38
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.